SlideShare ist ein Scribd-Unternehmen logo

Macro genics, inc. – product pipeline review – 2012

•Als DOCX, PDF herunterladen•
•
R
Rose088

Aarkstore Enterprise-MacroGenics, Inc. – Product Pipeline Review – 2012

Business
1 von 4
Aarkstore.com announces, The Latest market research report is available in its vast collection: MacroGenics,Inc. – Product PipelineReview – 2012 More about this report You can also request for sample page of above mention reports on sample@aarkstore.com Summary Global Markets Direct’s pharmaceuticals report, “MacroGenics, Inc. - Product Pipeline Review - 2012” provides data on the MacroGenics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, MacroGenics, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from MacroGenics, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - MacroGenics, Inc. - Brief MacroGenics, Inc. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of MacroGenics, Inc. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
Table of contents: List of Tables 4 List of Figures 5 MacroGenics, Inc. Snapshot 6 MacroGenics, Inc. Overview 6 Key Information 6 Key Facts 6 MacroGenics, Inc. – Research and Development Overview 7 Key Therapeutic Areas 7 MacroGenics, Inc. – Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products – Monotherapy 11 MacroGenics, Inc. – Pipeline Products Glance 12 MacroGenics, Inc. – Late Stage Pipeline 12 Phase III Products/Combination Treatment Modalities 12 MacroGenics, Inc. Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 MacroGenics, Inc. – Early Stage Pipeline Products 15 Discovery Products/Combination Treatment Modalities 15 MacroGenics, Inc. – Drug Profiles 16 DART For Autoimmune Disorders 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 DART mAb 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 mAbs 18 Product Description 18 Mechanism of Action 18 R&D Progress 18
List of Figures List of Tables are also include. For more related Reports Plz follow The link: Product Pipeline Review – 2012 http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1 MacroGenics, Inc. – Product Pipeline Review – 2012 TopoTarget A/S – Product Pipeline Review – 2012 YM BioSciences Inc. – Product Pipeline Review – 2012 ZIOPHARM Oncology, Inc. – Product Pipeline Review – 2012 Zydus Cadila Healthcare Limited – Product Pipeline Review – 2012 Acucela Inc. – Product Pipeline Review – 2012 Aldagen, Inc. – Product Pipeline Review – 2012 Bellicum Pharmaceuticals, Inc. – Product Pipeline Review – 2012 DiaKine Therapeutics, Inc. – Product Pipeline Review – 2012 Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012
Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: enquiry@aarkstore.com

Empfohlen

Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
Rose088
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012
Rose088
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
Rose088
 
Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012
Rose088
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012
Rose088
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012
Rose088
 
Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012
Rose088
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
Rose088
 

Empfohlen

Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
Rose088
 
Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012Cytokinetics, incorporated – product pipeline review – 2012
Cytokinetics, incorporated – product pipeline review – 2012
Rose088
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
Rose088
 
Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012
Rose088
 
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012
Rose088
 
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012
Rose088
 
Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012
Rose088
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
Rose088
 
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012
Rose088
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012
Rose088
 
Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012
Rose088
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
Rose088
 
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012
Rose088
 
Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012
Rose088
 
Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012
Rose088
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
Rose088
 
Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012
Rose088
 
Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012
Rose088
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012
Rose088
 
Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012
Rose088
 
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012
Rose088
 
Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012
Rose088
 
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012
Rose088
 
Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012
Rose088
 
Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012
Rose088
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015
Ambikabasa
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
Rose088
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012
Rose088
 
United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012
Rose088
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Rose088
 

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012
 
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012
 
Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012Pro strakan group plc – product pipeline review – 2012
Pro strakan group plc – product pipeline review – 2012
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
 
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012
 
Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012
 
Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012Osmotica pharmaceutical corp. – product pipeline review – 2012
Osmotica pharmaceutical corp. – product pipeline review – 2012
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
 
Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012Mixed dyslipidemia – pipeline review, h1 2012
Mixed dyslipidemia – pipeline review, h1 2012
 
Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012Astellas pharma inc. – product pipeline review – 2012
Astellas pharma inc. – product pipeline review – 2012
 
Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012Pique therapeutics – product pipeline review – 2012
Pique therapeutics – product pipeline review – 2012
 
Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012
 
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012
 
Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012Action pharma a s – product pipeline review – 2012
Action pharma a s – product pipeline review – 2012
 
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012
 
Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012
 
Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015Co mentis, inc. product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
 
Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012Alchemia limited – product pipeline review – 2012
Alchemia limited – product pipeline review – 2012
 

Ähnlich wie Macro genics, inc. – product pipeline review – 2012

Ähnlich wie Macro genics, inc. – product pipeline review – 2012 (18)

United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
 
Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012Viventia biotechnologies inc. – product pipeline review – 2012
Viventia biotechnologies inc. – product pipeline review – 2012
 
Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012Maruho co.,ltd. – product pipeline review – 2012
Maruho co.,ltd. – product pipeline review – 2012
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
 
Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012Nuon therapeutics, inc. – product pipeline review – 2012
Nuon therapeutics, inc. – product pipeline review – 2012
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
 
Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012Sym bio pharmaceuticals limited – product pipeline review – 2012
Sym bio pharmaceuticals limited – product pipeline review – 2012
 
Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
 
Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012Wockhardt limited – product pipeline review – 2012
Wockhardt limited – product pipeline review – 2012
 
Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
 
Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012Bacteremia – pipeline review, h1 2012
Bacteremia – pipeline review, h1 2012
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012
 
Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012Effimune – product pipeline review – 2012
Effimune – product pipeline review – 2012
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation product pipeline review - 2015Genzyme corporation product pipeline review - 2015
Genzyme corporation product pipeline review - 2015
 

Mehr von Rose088

Mehr von Rose088 (12)

India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeIndia wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternative
 
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016
 
Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012Hereditary angioedema (hae) – pipeline review, h2 2012
Hereditary angioedema (hae) – pipeline review, h2 2012
 
Congestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineCongestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipeline
 
Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)
 
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoptionDownstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoption
 
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricants
 
Mumbai
MumbaiMumbai
Mumbai
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asia
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical research
 

Kürzlich hochgeladen

Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
pr788182
 
Uneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration PresentationUneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration Presentation
uneakwhite
 
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pillsMifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Abortion pills in Kuwait Cytotec pills in Kuwait
 
Pre Engineered Building Manufacturers Hyderabad.pptx
Pre Engineered Building Manufacturers Hyderabad.pptxPre Engineered Building Manufacturers Hyderabad.pptx
Pre Engineered Building Manufacturers Hyderabad.pptx
Roofing Contractor
 
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
daisycvs
 

Kürzlich hochgeladen (20)

Falcon's Invoice Discounting: Your Path to Prosperity
Falcon's Invoice Discounting: Your Path to ProsperityFalcon's Invoice Discounting: Your Path to Prosperity
Falcon's Invoice Discounting: Your Path to Prosperity
 
Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024
 
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdf
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdfTVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdf
TVB_The Vietnam Believer Newsletter_May 6th, 2024_ENVol. 006.pdf
 
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
 
How to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityHow to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League City
 
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
 
Famous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st CenturyFamous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st Century
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
 
Organizational Transformation Lead with Culture
Organizational Transformation Lead with CultureOrganizational Transformation Lead with Culture
Organizational Transformation Lead with Culture
 
Uneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration PresentationUneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration Presentation
 
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSCROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
 
Buy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail AccountsBuy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail Accounts
 
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pillsMifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
 
Pre Engineered Building Manufacturers Hyderabad.pptx
Pre Engineered Building Manufacturers Hyderabad.pptxPre Engineered Building Manufacturers Hyderabad.pptx
Pre Engineered Building Manufacturers Hyderabad.pptx
 
Buy Verified TransferWise Accounts From Seosmmearth
Buy Verified TransferWise Accounts From SeosmmearthBuy Verified TransferWise Accounts From Seosmmearth
Buy Verified TransferWise Accounts From Seosmmearth
 
Arti Languages Pre Seed Teaser Deck 2024.pdf
Arti Languages Pre Seed Teaser Deck 2024.pdfArti Languages Pre Seed Teaser Deck 2024.pdf
Arti Languages Pre Seed Teaser Deck 2024.pdf
 
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
 
Power point presentation on enterprise performance management
Power point presentation on enterprise performance managementPower point presentation on enterprise performance management
Power point presentation on enterprise performance management
 
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
 

Macro genics, inc. – product pipeline review – 2012

  • 1. Aarkstore.com announces, The Latest market research report is available in its vast collection: MacroGenics,Inc. – Product PipelineReview – 2012 More about this report You can also request for sample page of above mention reports on sample@aarkstore.com Summary Global Markets Direct’s pharmaceuticals report, “MacroGenics, Inc. - Product Pipeline Review - 2012” provides data on the MacroGenics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, MacroGenics, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from MacroGenics, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - MacroGenics, Inc. - Brief MacroGenics, Inc. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of MacroGenics, Inc. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • 2. Table of contents: List of Tables 4 List of Figures 5 MacroGenics, Inc. Snapshot 6 MacroGenics, Inc. Overview 6 Key Information 6 Key Facts 6 MacroGenics, Inc. – Research and Development Overview 7 Key Therapeutic Areas 7 MacroGenics, Inc. – Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products – Monotherapy 11 MacroGenics, Inc. – Pipeline Products Glance 12 MacroGenics, Inc. – Late Stage Pipeline 12 Phase III Products/Combination Treatment Modalities 12 MacroGenics, Inc. Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 MacroGenics, Inc. – Early Stage Pipeline Products 15 Discovery Products/Combination Treatment Modalities 15 MacroGenics, Inc. – Drug Profiles 16 DART For Autoimmune Disorders 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 DART mAb 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 mAbs 18 Product Description 18 Mechanism of Action 18 R&D Progress 18
  • 3. List of Figures List of Tables are also include. For more related Reports Plz follow The link: Product Pipeline Review – 2012 http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1 MacroGenics, Inc. – Product Pipeline Review – 2012 TopoTarget A/S – Product Pipeline Review – 2012 YM BioSciences Inc. – Product Pipeline Review – 2012 ZIOPHARM Oncology, Inc. – Product Pipeline Review – 2012 Zydus Cadila Healthcare Limited – Product Pipeline Review – 2012 Acucela Inc. – Product Pipeline Review – 2012 Aldagen, Inc. – Product Pipeline Review – 2012 Bellicum Pharmaceuticals, Inc. – Product Pipeline Review – 2012 DiaKine Therapeutics, Inc. – Product Pipeline Review – 2012 Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012
  • 4. Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: enquiry@aarkstore.com